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Abstract
Background: Patients with Brugada syndrome (BrS) are known to have arrhythmic 
events after alcohol drinking and are recommended to avoid its excessive intake. 
Mechanisms underlying the alcohol‐induced cardiac events are however unknown. 
This study aimed to test the hypothesis whether activity of alcohol‐metabolizing en‐
zymes determines fatal arrhythmic events after drinking alcohol.
Methods: A total of 198 Japanese patients with BrS were enrolled in this study. 
These patients were classified into symptomatic (n = 90) and asymptomatic (n = 108) 
groups. The former was divided into an alcohol‐related group (syncope after alcohol 
drinking, n = 16) and an alcohol‐unrelated group (n = 74). Polymerase chain reaction 
was performed to determine genetic variants of genes encoding alcohol dehydroge‐
nase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2).
Results: The genotype distribution for ALDH2 was not significantly different between 
symptomatic and asymptomatic groups and between alcohol‐related and alcohol‐ 
unrelated groups. The genotype distribution for ADH1B was not significantly differ‐
ent between symptomatic and asymptomatic groups, but the genotype ADH1B His/
His was significantly more prevalent in the alcohol‐related group than in the alcohol‐
unrelated group (81.3% vs 50%, P = .023). In multivariate logistic regression analysis, 
the genotype of ADH1B His/His was independently associated with syncope after 
alcohol drinking (odds ratio, 5.746; 95% confidence interval, 1.580‐28.421; P = .007).
Conclusions: Arrhythmic events after alcohol drinking was associated with enhanced 
activity of alcohol‐metabolizing enzyme ADH1B in our cohort of BrS. Therefore, the 
lifestyle change to avoid the excessive alcohol intake deserves attention.
K E Y W O R D S
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1  | INTRODUC TION
Brugada syndrome (BrS) is diagnosed as a coved‐type ST‐segment 
elevation in the right precordial leads.1 Patients with BrS develop 
symptoms including ventricular fibrillation (VF), aborted sudden 
death, syncope, or nocturnal agonal respiration. Previous reports2,3 
and consensus guideline1 have shown that alcohol drinking is asso‐
ciated with occurrence of syncope in BrS. Alcohol taken into a body 
is metabolized by two enzymes, namely alcohol dehydrogenase 1B 
(ADH1B) and aldehyde dehydrogenase 2 (ALDH2). Alcohol is me‐
tabolized to acetaldehyde by ADH1B and sequentially converted to 
acetate by ALDH2 (Figure 1). The activity of the two enzymes indi‐
vidually varies depending on genetic variants of the enzymes.
The prevalence of BrS is relatively higher in the Southeast Asian 
countries including Japan compared to the Western countries.1,4,5 
This geographical prevalence of BrS is similar to that of loss‐of‐func‐
tion type variants in alcohol‐metabolizing enzymes: ADH1B and 
ALDH2, which are more common in Asians than in Caucasians.6‒8 
More recently, Watanabe et al9 reported that habitual excessive al‐
cohol drinkers among Japanese BrS patients with implantable car‐
dioverter‐defibrillator (ICD) implantation have more fatal arrhythmic 
events. Therefore, we hypothesized that genetic polymorphisms 
of the alcohol‐metabolizing enzymes would be associated with ar‐
rhythmic events in BrS, thus contributing to the pathophysiology 
and arrhythmogenesis of the disease. The purpose of this study was 
to test this hypothesis.
2  | METHODS
2.1 | Study population (Figure 2)
The study subjects consisted of 198 BrS Japanese patients (176 men 
with a mean age of 44.9 ± 15.8 years and 22 women with a mean age 
of 47.4 ± 17.6 years). The diagnosis of BrS was made on the basis of 
electrocardiogram (ECG) findings according to the expert consen‐
sus statement.1 In 198 patients, 90 patients (45.5%: 85 men, mean 
43.1 ± 15.2 years; 5 women, mean 39.8 ± 19.1 years) had history of 
syncope and/or aborted sudden cardiac death caused by ventricular 
tachycardia or fibrillation (symptomatic group). According to medical 
records, after other causes of syncope like neutrally mediated syn‐
cope had been excluded, all the symptomatic patients were thought 
to have “arrhythmic syncope.” When fatal arrhythmias were recorded 
by ECG, they were either transient VT/VF or cardiopulmonary arrest 
due to continued VF. In contrast, remaining 108 patients (54.5%: 91 
men, mean 46.5 ± 16.3 years; 17 women, mean 49.7 ± 17.2 years) did 
not have any episodes of syncope (asymptomatic group) (Figure 2).
The patients of the symptomatic group were further classified 
into two groups: 16 patients (all men, mean 46.8 ± 13.3 years) who 
suffered from syncope after drinking alcohol (alcohol‐related group) 
and 74 patients (69 men, mean 42.3 ± 15.5 years; 5 women, mean 
39.8 ± 19.1 years) who had no history of syncope after drinking al‐
cohol (alcohol‐unrelated group) (Figure 2). Syncope after alcohol 
drinking is defined as follows: syncope occurred within 6 hours after 
alcohol drinking, and the amount of drinking alcohol was not spec‐
ified. Whether or not family history of sudden death was present 
was evaluated in all patients enrolled in this study. Family history 
was defined as at least one first‐degree family member had died sud‐
denly with a type 1 Brugada ECG pattern during their ante mortem 
or before the age of 45 years in the absence of known heart disease. 
The study was approved by the ethics committee of Shiga University 
of Medical Science (approval number: 27‐161), and written informed 
consent was obtained from each patient.
2.2 | Determination of ADH1B and 
ALDH2 genotypes
Genomic DNA was extracted from blood lymphocyte as previ‐
ously reported.10 Subsequently, genotyping was performed using 
TaqMan single‐nucleotide polymorphism (SNP) genotyping assay 
(Applied Biosystems) in a real‐time PCR system (StepOnePlus™; 
Applied Biosystems) for ADH1B (His48Arg; rs1229984) and ALDH2 
(Glu504Lys; rs671). Amplification conditions were 95°C for 20 sec‐
onds, 40 cycles of 95°C for 3 seconds, and 60°C for 20 seconds. The 
genotyping was performed with a blind method to the identification 
of the study subjects.
2.3 | Statistical analysis
The baseline clinical data were expressed as the mean ± standard de‐
viation for continuous variables. A comparison between two groups 
F I G U R E  1   A scheme showing the process of alcohol taken into 
a body metabolized by two enzymes
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was performed with Student's t test or the nonparametric Mann‐
Whitney's U test, as appropriate. For discrete variables, the data 
were expressed as counts and percentages. Categorical variables 
were compared with chi‐squared test. Allele frequencies determined 
by direct gene counting and genotype distributions were checked 
for departure from Hardy‐Weinberg equilibrium using the Pearson's 
chi‐squared test. A two‐tailed value of P < .05 was considered to 
be statistically significant. A multiple logistic regression analysis was 
performed to determine the risk factors of syncope after drinking al‐
cohol. Independent variables were included on the basis of theoreti‐
cal and clinical grounds. Data analyses were conducted using JMP® 
10 (SAS Institute Inc.).
3  | RESULTS
3.1 | Characteristics of the study patients
Table 1A shows the comparison of the clinical characteristics be‐
tween symptomatic and asymptomatic groups. There was no signifi‐
cant difference in age, family history of sudden death, the frequency 
of spontaneous type1 Brugada ECG pattern between the two 
groups. The prevalence of male gender was significantly higher in 
the symptomatic than in the asymptomatic group.
Table 1B shows the comparison of the clinical characteristics 
between alcohol‐related and unrelated groups. There was no sig‐
nificant difference in age, gender, family history of sudden death, 
the frequency of spontaneous type1 Brugada ECG pattern, aborted 
sudden death, documented VT/VF, VF induced by electrophysiol‐
ogy study, and ICD implantation between the two groups. Based on 
ICD follow‐up, although statistically not significant, VF recurrence 
rate was higher in the alcohol‐related group (25% vs 6.5%, P = .096). 
Indeed, one of our cases experienced appropriate ICD therapy for 
four episodes of recurrent VF, which were all associated with alcohol 
drinking. In this group, average time interval between the start of 
drinking and cardiac events was 3.5 hours.
3.2 | Genotype distribution of ADH1B and ALDH2
Table 2A shows distribution of genotypes for ADH1B and ALDH2 
in the symptomatic and the asymptomatic groups. A vast majority 
of the study patients had the variant ADH1B His genotype (ADH1B 
Arg/His or ADH1B His/His) and the variant ALDH2 Glu genotype 
(ALDH2 Glu/Glu or ALDH2 Glu/Lys) in both groups (ADH1B His: 
92.3% vs 95.4%, P = .355; ALDH2 Glu: 91.1% vs 93.5%, P = .524). The 
genotype distributions of the two genes did not deviate from the 
Hardy‐Weinberg equilibrium: ADH1B gene, χ2 = 0.223, P = .64 for 
the symptomatic group and χ2 = 1.029, P = .31 for the asymptomatic 
group; ALDH2 genes, χ2 = 3.324, P = .07 for the symptomatic group 
and χ2 = 0.017, P = .90 for the asymptomatic group. There was no 
significant overall difference in genotype distribution for ADH1B and 
ALDH2 in the two groups (ADH1B: χ2 = 1.013, P = .564, Figure 3A; 
ALDH2: χ2 = 2.065, P = .379, Figure 3B).
Table 2B shows distribution of genotypes for ADH1B and ALDH2 
in the alcohol‐related syncope group and the alcohol‐unrelated 
group. A vast majority of the study patients had the variant ADH1B 
His genotype and the ALDH2 Glu genotype in both0groups (ADH1B 
His: 93.8% vs 91.9%, P = .801; ALDH2 Glu: 93.8% vs 90.6%, P = .683). 
The genotype distribution of the two genes did not deviate from the 
Hardy‐Weinberg equilibrium: ADH1B gene, χ2 = 2.939, P = .09 for 
the alcohol‐related group and χ2 = 0.019, P = .89 for the alcohol‐un‐
related group; ALDH2 gene, χ2 = 0.118, P = .73 for the alcohol‐re‐
lated group and χ2 = 3.394, P = .07 for the alcohol‐unrelated group. 
There was no significant overall difference in genotype distribution 
for ADH1B and ALDH2 between the two groups (ADH1B: χ2 = 5.470, 
P = .065, Figure 4A; ALDH2: χ2 = 0.190, P = .301, Figure 4B).
The prevalence of ADH1B His/His was significantly higher in the 
alcohol‐related group than in the alcohol‐unrelated group (81.3% vs 
50%, P = .023). When compared to those carrying ADH1B Arg/His 
or ADH1B Arg/Arg (Figure 5), frequency of alcoholic‐related syncope 
was significantly higher in ADH1B His/His (26% vs 7.5%; odds ratio, 
4.330; 95% confidence interval, 1.140–16.475; P = .023).
F I G U R E  2   Subgroup of study 
population
     |  755WU et al.
TA B L E  1   Comparison of clinical characteristics





(n = 108) P‐value
Age (years) 42.6 ± 15.3 47.0 ± 16.4 .077
Male gender, n (%) 85 (94.4) 91 (84.3) .023
FH of SD, n (%) 9 (10) 10 (9.3) .860
Spontaneous of type 1 ECG, n (%) 50 (55.6) 46 (42.6) .069
B. Alcohol‐related group vs alcohol‐unrelated group
Variables
Alcohol‐related 
group (n = 16)
Alcohol‐unrelated 
group (n = 74) P‐value
Age (years) 46.8 ± 13.3 42.1 ± 15.7 .275
Male gender, n (%) 16 (100) 69 (93.2) .285
FH of SD, n (%) 0 (0) 9 (12.2) .141
Spontaneous of type 1 ECG, n (%) 10 (62.5) 40 (54.1) .538
Arrhythmia Syncope 16 (100) 74 (100) —
Aborted sudden death 0 (0) 2 (2.7) .506
Documented VF 7 (43.75) 34 (45.95) .973
VF induced by EPS 2 (12.5) 15 (20.27) .472
ICD 8 (50) 46 (62.2） .368
Appropriate shock deliveries 2/8 (25) 3/46 (6.5) .096
Note: Data are expressed as mean ± standard deviation or n (%).
Abbreviations: FH, family history; EPS, electrophysiologic study; ICD, implantable cardioverter defibrillator; SD, sudden death; VF, ventricular 
fibrillation.
TA B L E  2   Frequency distribution of genotypes for ADH1B and ALDH2





(n = 108) P‐value
ADH1B gene
ADH1B Arg/Arg, n (%) 7 (7.8) 5 (4.6) .355
ADH1B Arg/His, n (%) 33 (36.7) 45 (41.7) .473
ADH1B His/His, n (%) 50 (55.6) 58 (53.7) .794
ALDH2 gene
ALDH2 Glu/Glu, n (%) 56 (62.2) 59 (54.6) .281
ALDH2 Glu/Lys, n (%) 26 (28.9) 42 (38.9) .140
ALDH2 Lys/Lys, n (%) 8 (8.9) 7 (6.5) .524





group (n = 74) P‐value
ADH1B gene
ADH1B Arg/Arg or ADH1B Arg/His, n (%) 3 (18.8) 37 (50.0) .023
ADH1B His/His, n (%) 13 (81.2) 37 (50.0)
ALDH2 gene
ALDH2 Glu/Glu, n (%) 10 (62.5) 46 (62.2) .980
ALDH2 Glu/Lys, n (%) 5 (31.3) 21 (28.4) .818
ALDH2 Lys/Lys, n (%) 1 (6.3) 7 (9.5) .683
Note: Data are expressed as number (%).
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Multivariate regression logistic analysis revealed that the genotype 
of ADH1B His/His was significantly and independently associated with 
syncope after drinking alcohol, after adjustment for age, ADH1B His/
His genotypes, spontaneous type1 Brugada ECG pattern (ADH1B His/
His gene, odds ratio, 5.746; 95% confidence interval, 1.580‐28.421; 
P = .007; Table 3). Because patients in the alcohol‐related group were 
all male and did not have family history of sudden death, both gender 
and family history were not included as the confounding factors.
F I G U R E  3   Comparison of frequency of symptomatic patients to all patients enrolled in this study according to genotypes of ADH1B 
and ALDH2. A, There was no difference in the frequency of the symptomatic patients by ADH1B genotype. B, There was no difference in 
the frequency of the symptomatic patients by ALDH2 genotype. Abbreviations: ADH1B, alcohol dehydrogenase subunit; ALDH2, aldehyde 
dehydrogenase 2
F I G U R E  4   Comparison of frequency of patients with alcohol‐related syncope to symptomatic patients in this study according to 
genotypes of ADH1B and ALDH2. A, There was no difference in the frequency of the patients with alcohol‐related syncope by ADH1B 
genotype. B, There was no difference in the frequency of the patients with alcohol‐related syncope by ALDH2 genotype. Abbreviations: 
ADH1B, alcohol dehydrogenase subunit; ALDH2, aldehyde dehydrogenase 2
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4  | DISCUSSION
The present study found: (a) ~20% of fatal arrhythmic events were re‐
lated to alcohol drinking in our cohort of symptomatic BrS, (b) the dis‐
tribution for ALDH2 genotypes was not significantly different between 
symptomatic and asymptomatic groups or between alcohol‐related 
and alcohol‐unrelated syncope groups, (c) the distribution for ADH1B 
genotypes was not significantly different between symptomatic and 
asymptomatic groups, but the genotype ADH1B His/His was signifi‐
cantly more frequent in the alcohol‐related group compared to the 
alcohol‐unrelated group, and (d) the genotype ADH1B His/His was in‐
dependently associated with syncope after drinking alcohol (Table 3).
Alcohol (ethanol) exerts various physiological responses 
(Figure 1).11 It is metabolized by two enzymes, namely ADH1B and 
ALDH2. The former metabolizes ethanol to acetaldehyde in the cy‐
tosol; the latter acetaldehyde to acetic acid in the mitochondria. 
The ADH1B gene is located on chromosome 4, and its single‐nucle‐
otide polymorphism (SNP: rs1229984) replaces arginine to histidine 
at residue 47 (Arg47His). The ALDH2 on chromosome 12 has also a 
SNP (rs671) which substitutes glutamate with lysine at position 504 
(Glu504Lys). These two SNPs exert loss‐of‐function effects and are 
more common in East Asians than in Caucasians and play essential 
roles in alcohol‐induced physical reactions.11‒13
The variant ADH1B His/His is a super‐active subunit of ADH1B 
and possesses ~40 times more efficient ethanol metabolizing ac‐
tivity compared to ADH1B Arg/Arg,11,14 and is seen in 60% of 
Japanese.15,16 In contrast, 57% of Japanese are homozygous for the 
ALDH2 Glu/Glu which has normal enzymatic activity. Homozygotes 
ALDH2 Lys/Lys occur in 5%–10% and possess only ~4% of normal 
enzymatic activity.17
Among Japanese BrS patients implanted with ICD, Watanabe et al9 
reported that habitual excessive alcohol drinkers showed significantly 
more frequent recurrence of fatal arrhythmic events. Because carriers 
with ADH1B His/His have stronger ability of alcohol metabolism and 
higher level of alcohol consumption,11,18 their report may suggest the 
same results as our findings in that the ADH1B His/His genotype was 
significantly more frequent among the patients suffering alcohol‐re‐
lated fatal arrhythmic events. Our results also support the recommen‐
dation of 2014 Expert Consensus Statement1 to avoid the excessive 
alcohol intake to prevent the arrhythmic risk as a lifestyle change.
The super‐active ADH1B variant results in an earlier and higher 
peak of blood acetaldehyde level. Acetaldehyde then stimulates the 
sympathetic nervous tone through the release of catecholamine from 
sympathetic nervous terminals.19,20 The patients carrying this SNP 
might have an earlier and larger increase in sympathetic tone than 
those with other SNP carriers. On cessation of ethanol drinking, the 
larger sympathetic stimulation declines with disappearance of acetal‐
dehyde, and the following stronger parasympathetic activation could 
be possible to occur. The strongest alcohol metabolizers may have a 
large meal concurrently with a large amount of alcohol consumption, 
producing a full stomach condition. It is well known that, a full stomach 
test can unmask type1 ECG by through the increased vagal activity.21
It is well known that autonomic function influences the severity 
of BrS.22‒25 Both experimental and clinical studies have shown that 
ST‐segment elevation, a marker of increased risk of arrhythmic events, 
is mitigated by the administration of beta‐adrenergic agonists and en‐
hanced by parasympathetic agonists.26,27 In this connection, Makimoto 
et al28 reported that 34 out of 93 patients with BrS showed significant 
ST segment elevation in V1 to V3 leads during the recovery phase after 
exercise tolerance test, indicating the involvement of parasympathetic 
reactivation. In these 34 patients, clinical prognosis was significantly 
worse and SCN5A mutations were more frequently identified.
There are several reports on excessive alcohol consumption and 
increased risk of sudden cardiac death.29,30 In an experimental study, 
excessive alcohol directly exerts proarrhythmic effects by inhibiting 
sodium and calcium channels.31,32
F I G U R E  5   Comparison of frequency 
of patients with alcohol‐related syncope 
to patients with symptomatic patients 
in this study according to genotypes of 
ADH1B His/His The frequency of ADH1B 
His/His was significantly higher than 
genotypes of ADH1B Arg/His and ADH1B 
Arg/Arg. Abbreviation: ADH1B, alcohol 
dehydrogenase subunit
TA B L E  3   Multivariate logistic regression analysis for syncope 
after drinking alcohol
Variable OR P > |z| 95%CI
Age 0.109 .141 0.004‐2.046




Abbreviations: CI, confidence interval; OR, odds ratio.
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4.1 | Limitations
Although it is known that alcohol‐induced flushing33,34 and fre‐
quency of habitual drinking are useful information to learn if a sub‐
ject tolerates alcohol intake, the medical record was not available. 
The ethnicity‐dependent difference of frequency of alcohol‐related 
syncope in BrS remains unknown because our study population was 
limited to the Japanese.
5  | CONCLUSION
Arrhythmic events after alcohol drinking in BrS patients were associ‐
ated with enhanced activity of alcohol‐metabolizing enzyme caused 
by ADH1B His/His, supporting the recommendation of 2014 Expert 
Consensus Statement in that the excessive alcohol intake should be 
avoided.1
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